OpGen Announces Collaborator in Verification Study for Acuitas® Test Mar 13, 2018 07:30AM
OpGen Announces Collaborator in Verification Study for Acuitas® Test Mar 13, 2018 07:30AM
OpGen Announces Date of Fourth Quarter and Fiscal Year 2017 Financial Results Conference Call Mar 5, 2018 04:00PM
OpGen to Present at the Cowen and Company 38th Annual Health Care Conference Mar 1, 2018 11:50AM
OpGen Strengthens Supplier Relationship to Use Industry-Leading Real-Time PCR Technology for New Acuitas® Tests Feb 13, 2018 07:30AM


Feb 13, 2018 07:30AM OpGen Strengthens Supplier Relationship to Use Industry-Leading Real-Time PCR Technology for New Acuitas® Tests
Feb 1, 2018 08:13AM OpGen Introduces New RUO Rapid Test for Infection Control and Surveillance Studies
Jul 12, 2017 01:28PM OpGen Acuitas® MDRO Gene Test Approved by NY State Department of Health
Jun 19, 2017 08:09AM OpGen (OPGN) Reports Supply Agreement with Thermo Fisher Scientific (TMO) for Technology to Advance Acuitas Rapid Test
Jun 19, 2017 08:00AM OpGen Signs Supply Agreement to Use Thermo Fisher Scientific’s Technology to Advance Acuitas® Rapid Test
Jun 15, 2017 03:03PM OpGen’s Acuitas® Detection Technology Utilized in Publication Revealing Prevalence of CRE in Washington D.C. Healthcare Facilities
Jun 5, 2017 08:10AM OpGen (OPGN) Says Data at ASM Microbe Demonstrates Potential of Acuitas Products
Jun 5, 2017 08:00AM OpGen Data at ASM Microbe 2017 Demonstrates Potential of Acuitas Products for Predicting Antibiotic Susceptibility and Infection Control
May 30, 2017 08:00AM OpGen to Receive Ignaz Semmelweis Award for Commitment to Combatting Infection Deaths
May 25, 2017 08:00AM OpGen to Present Advancements in Antibiotic Susceptibility and Whole Genome Sequencing at ASM Microbe 2017
Apr 27, 2017 08:00AM OpGen Appoints Tina S. Nova, Ph.D. to Board of Directors
Apr 26, 2017 04:00PM OpGen Announces 2017 First Quarter Financial Results
Apr 25, 2017 08:00AM OpGen Highlights Capabilities of its Acuitas® Technologies to Rapidly Predict Antibiotic Susceptibility Using Drug Resistance Gene Profiles at ECCMID
Apr 19, 2017 04:15PM OpGen Announces Date of First Quarter 2017 Financial Results Conference Call
Apr 13, 2017 02:39PM UPDATE -- OpGen to Present Antibiotic Resistance Prediction Data at 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
Apr 12, 2017 04:30PM OpGen to Present Antibiotic Resistance Prediction Data at 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
Apr 10, 2017 09:00AM Bioverativ Appoints Tim Harris Executive Vice President, Research and Development
Mar 23, 2017 04:01PM OpGen Announces 2016 Fourth Quarter and Year End Financial Results
Mar 16, 2017 04:30PM OpGen Announces Date of 2016 Fourth Quarter and Year End Financial Results Conference Call
Mar 1, 2017 08:00AM OpGen to Present at the Cowen and Company 37th Annual Health Care Conference
Feb 14, 2017 12:04PM OpGen (OPGN) Announces Prelim. Data Demonstrating Ability to Rapidly and Accurately Predict Bacterial Antibiotic Susceptibility with Gene Profiles
Feb 14, 2017 12:00PM OpGen Presents Rapid Acuitas Genetic Test Data at Advances in Genome Biology and Technology Meeting
Jan 26, 2017 05:38PM OpGen Reports Preliminary Fourth Quarter and Full Year 2016 Financial Results
Dec 19, 2016 03:30PM OpGen Supports Passage of Landmark 21st Century Cures Act to Expedite Development of Solutions for Bacterial Infections
Dec 16, 2016 09:28AM OpGen (OPGN) Issued 3.6M in Common Stock in ATM Offering
Dec 16, 2016 09:26AM OpGen Provides ATM Program Update
Nov 14, 2016 07:14AM OpGen (OPGN), Merck (MRK) Enter Rapid Diagnostics, IT Products Development Collaboration
Nov 14, 2016 07:00AM OpGen Collaborates With Merck to Develop Novel Rapid Diagnostics and Informatics Tools to Combat Antibiotic Resistance
Oct 27, 2016 04:25PM Large Integrated Health Outcomes Study Reveals Shifting Epidemiology In Drug Resistant Organisms
Oct 26, 2016 08:00AM OpGen’s Infectious Disease Portfolio Highlighted at IDWeek 2016
Oct 24, 2016 04:01PM OpGen Reports 2016 Third Quarter Financial Results and Provides Business Update
Oct 19, 2016 05:10PM OpGen Announces Date of Third Quarter 2016 Financial Results Conference Call
Sep 7, 2016 07:30AM OpGen to Present at the Rodman & Renshaw 18th Annual Global Investment Conference
Aug 9, 2016 04:02PM OpGen Reports 2016 Second Quarter Financial Results and Provides Business Update
Aug 2, 2016 08:30AM OpGen, Inc. Announces Timing for Second Quarter Financial Results and Conference Call
Jun 20, 2016 12:30PM OpGen Highlights Strong Performance of Acuitas® Resistome Test at ASM Microbe 2016
May 20, 2016 10:14AM OpGen Announces Closing of $10 Million Private Placement
May 17, 2016 09:00AM OpGen Supports New White House National Microbiome Initiative
May 12, 2016 04:01PM OpGen Reports 2016 First Quarter Financial Results and Business Update
May 4, 2016 07:30AM OpGen and District of Columbia Hospital Association Complete First Citywide Quantification of Multidrug-Resistant Organism (MDRO) Prevalence in Washington, D.C.-based Healthcare Facilities
May 2, 2016 12:22PM OpGen Appoints Harry J. D'Andrea to Board of Directors
Apr 11, 2016 07:44AM OpGen (OPGN) Announces Presentation of Positive QuickFISH Data at ECCMID
Apr 11, 2016 07:30AM New Study Data Show OpGen’s QuickFISH® Blood Culture Pathogen ID Tests to be Rapid and Cost-Effective, with Utility to Inform Antimicrobial Stewardship Decisions
Jul 13, 2015 12:00PM Fluidigm and OpGen Enter Into Strategic Agreement to Develop Multi-Drug Resistance Testing Kits and Equipment
Jul 13, 2015 12:00PM Fluidigm and OpGen Enter into Strategic Agreement to Develop Multi-Drug Resistance Testing Kits and Equipment